Results 101 to 110 of about 25,991 (218)

Miglustat therapy in the French cohort of paediatric patients with Niemann-Pick disease type C

open access: yesOrphanet Journal of Rare Diseases, 2012
Background Niemann-Pick disease type C (NP-C) is a rare neurovisceral lysosomal lipid storage disease characterized by progressive neurological deterioration. Published data on the use of miglustat in paediatric patients in clinical practice settings are
Héron Bénédicte   +13 more
doaj   +1 more source

Acid Sphingomyelinase Regulates the Localization and Trafficking of Palmitoylated Proteins [PDF]

open access: yes, 2019
In human, loss of Acid Sphingomeylinase (ASM/SMPD1) causes Niemann-Pick Disease, type A. ASM hydrolyzes sphingomyelins to produce ceramides but protein targets of ASM remain largely unclear. ...
Kim, Yongsoon   +7 more
core   +2 more sources

Type C Niemann-Pick disease [PDF]

open access: yesBritish Journal of Haematology, 2000
G A, Kennedy   +5 more
openaire   +3 more sources

Altered vitamin E status in Niemann-Pick type C disease

open access: yesJournal of Lipid Research, 2011
Vitamin E (α-tocopherol) is the major lipid-soluble antioxidant in many species. Niemann-Pick type C (NPC) disease is a lysosomal storage disorder caused by mutations in the NPC1 or NPC2 gene, which regulates lipid transport through the endocytic pathway.
L. Ulatowski   +10 more
doaj   +1 more source

Miglustat in Niemann-Pick disease type C patients: a review

open access: yesOrphanet Journal of Rare Diseases, 2018
Objective Niemann-Pick disease type C (NP-C) is a rare, autosomal recessive, neurodegenerative disease associated with a wide variety of progressive neurological manifestations.
Mercè Pineda   +2 more
doaj   +1 more source

[Niemann-Pick disease (type C)].

open access: yesSrpski arhiv za celokupno lekarstvo, 2006
A 15-year old girl with slowly progressive gait and speech disorders, and with impairment of mental ability, is decsribed. The disease appeared 18 months before the first hospitalization at the Department of Neurology and Physchiatry for Children and Young People.
D D, Milovanovitsh   +2 more
openaire   +1 more source

Assessment of plasma chitotriosidase activity, CCL18/PARC concentration and NP-C suspicion index in the diagnosis of Niemann-Pick disease type C: a prospective observational study [PDF]

open access: yes, 2017
Additional file 1.
Carmen Dominguez   +9 more
core   +3 more sources

Niemann-Pick disease type C: a case series of Brazilian patients

open access: yesArquivos de Neuro-Psiquiatria, 2014
The aim of the study was to analyze a series of Brazilian patients with Niemann-Pick disease type C (NP-C). Method Correlations between clinical findings, laboratory data, molecular findings and treatment response are presented.
Paulo José Lorenzoni   +12 more
doaj   +1 more source

Immune dysfunction in Niemann‐Pick disease type C

open access: yesJournal of Neurochemistry, 2015
AbstractLysosomal storage diseases are inherited monogenic disorders in which lysosome function is compromised. Although individually very rare, they occur at a collective frequency of approximately one in five thousand live births and usually have catastrophic consequences for health. The lysosomal storage diseases Niemann‐Pick disease type C (NPC) is
Platt, Nick   +7 more
openaire   +2 more sources

Requirement of Npc1 and availability of cholesterol for early embryonic cell movements in zebrafish[S]

open access: yesJournal of Lipid Research, 2011
Niemann-Pick disease, type C (NP-C), often associated with Niemann-Pick disease, type C1 (NPC1) mu­tations, is a cholesterol-storage disorder characterized by cellular lipid accumulation, neurodegeneration, and reduced steroid production.
Tyler Schwend   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy